|
|
|
| March 2002, Volume 26, Number 3, Pages 398-402 |
| Table of contents Previous Article Next [PDF] |
 |
| Paper |
| A novel method of measuring intra-abdominal fat volume using helical computed tomography |
 |
| J Kobayashi1, N Tadokoro1, M Watanabe2 and M Shinomiya1 |
 |
1Department of Internal Medicine, Chibaken Saiseikai Narashino Hospital, Narashino, Japan
2Department of Radiology, Chibaken Saiseikai Narashino Hospital, Narashino, Japan
|
Correspondence to: J Kobayashi, 1-1-1 Izumicho, Narashino City, Chiba Prefecture 275-8580 Japan. E-mail: koba231@attglobal.net |
 |
| Abstract |
 | OBJECTIVES: We present a novel method of scanning for intra-abdominal fat volume by helical computed tomography (CT), and describe the clinical significance of measuring the volumes of intra-abdominal visceral fat (Vvol) and subcutaneous fat (Svol) vs these respective areas determined by conventional slice-by-slice CT at the umbilical level. METHOD: Subjects with obesity or hyperlipidemia (79 men, 74 women) were recruited for this study. We obtained helical CT scans with a tube current of 150 mA, voltage of 120 kV and 2:1 pitch (table speed in relation to slice thickness), starting at the upper edge of the liver and continuing until the pelvis. The intra-abdominal visceral fat volume was measured by drawing a line within the muscle wall surrounding the abdominal cavity. The abdominal subcutaneous fat volume was calculated by subtracting the visceral fat volume from the total abdominal fat volume. By comparison, the intra-abdominal visceral and subcutaneous fat areas were determined at the umbilical level by the established slice-by-slice CT scanning technique. RESULTS: Vvol was correlated positively with visceral fat area (Varea) measured by conventional CT in both genders (in men (n=79) Vvol vs Varea, r=0.81 P<0.0001; in women (n=74) Vvol vs Varea, r=0.85, P<0.0001). Svol also showed a positive correlation with subcutaneous fat area (Sarea) in both genders (in men (n=78) Svol vs Sarea, r=0.95, P<0.0001; in women (n=74) Svol vs Sarea, r=0.92, P<0.0001). CONCLUSION: We have reported a novel method for measuring intra-abdominal fat volume by the use of helical CT. International Journal of Obesity (2002) 26, 398-402. DOI: 10.1038/sj/ijo/0801921 |
 |
| Keywords |
 | intra-abdominal fat; helical computed tomography; subcutaneous fat; visceral fat; leptin |
 |  |
Introduction
Helical computed tomography (CT) is a new volume acquisition mode in X-ray CT which was introduced in the late 1980s. This helical data set is obtained by moving the table on which the patient lies at constant speed, while the X-ray tube continuously rotates and a sustained exposure is made.1,2 Anatomical ranges are scanned continuously within the scanned volume. Helical CT is known to have a number of important potential advantages for examining the abdomen, compared with standard CT.3,4 In comparison to conventional CT, helical CT is less sensitive to motion artifacts and, because of the volume acquisition during breathing suspension, there is no misregistration due to different breathing levels. Until recently, however, there had been no study that applied this technique to the measurement of body fat mass. Rogalla et al5 reported with low-dose helical CT in 24 post-gastrectomy patients that percentage fat and percentage subcutaneous fat were significantly larger in women, as were percentage intra-abdominal and mediastinal fat in men.
It has been demonstrated that individuals with upper body fat accumulation are more susceptible to progression of atherosclerosis than those with lower body fat accumulation.6 In the 1980s the method of evaluating intra-abdominal visceral fat area using CT was reported, and this fat was suggested to play an important role in the development of diabetes mellitus, hypertension and hyperlipidemia.7,8,9,10 However, it remains to be clarified in what manner and to what extent individual fat tissue contributes to abdominal metabolism. In this study, therefore, we conducted helical CT to measure the precise value of fat accumulation and fat volume. We also investigated the relationship between visceral fat mass vs serum lipids by utilizing Vvol as an indicator of visceral fat accumulation as we presume that Vvol might be a more reliable indicator of metabolic disorders than Varea.
In recent years, adipocytes have been found to be responsible for the secretion of various kinds of hormones and cytokines,11 in contrast to the previous notion. Leptin, a cytokine identified and cloned by Zhang et al,12 which is produced and secreted mainly in adipocytes,13 is known to be involved in the neuroendocrine regulation of adiposity and its metabolic sequelae.14,15,16 Its plasma concentrations have been reported to be associated with body mass index (BMI) or percentage fat,17,18 or total body fat mass by dual energy X-ray absorptiometry.19 However, controversy still exists as to which fat mass is strongly associated with plasma leptin level, visceral or subcutaneous fat.20,21 As the importance of these various findings has become apparent, the requirement for improved techniques that can reliably measure intra-abdominal fat mass has become equally evident.
Here we present the basic principles and clinical significance of a novel method of scanning for intra-abdominal fat volume using helical CT. We also analyzed the relationship between intra-abdominal visceral (or subcutaneous) fat volume measured by this method (or these respective areas) vs serum leptin levels, as well as vs serum lipids.
|
 Materials and methods
Subjects (Table 1)
Subjects with obesity or hyperlipidemia (79 men aged 24-72, 74 women aged 26-73) were recruited for this study. Obesity was defined as individuals having a BMI greater than 25 kg/m2, according to the definition established by the Japan Society for Study of Obesity in 1999. Of the study subjects, five men and six women were on glibenclamide. However, none of the subjects received insulin therapy or insulin sensitizing agents such as biguanide or thiazolidinediones. Individuals with poorly controlled diabetes mellitus, kidney disease, liver disease and endocrinological disorders were excluded from this study. Of the study subjects, four men had received statins, two had probucol, five had fibrates, one had niacin and one had resin, while 10 women had received statins, two probucol, three fibrates and one niacin, but these drugs were discontinued at least 6 weeks before this study. Venous blood was drawn from the forearm after 12 h fasting for assay of serum lipid and lipoprotein levels. Serum total cholesterol (TC) and triglyceride (TG) concentrations were measured enzymatically. High-density lipoprotein cholesterol (HDL-C) was measured after precipitation of whole plasma with heparin calcium.
Scanning for intra-abdominal fat volume in spiral CT
The subjects were examined in a supine position with both arms stretched above the head using Toshiba X-Vision GX (Tokyo, Japan). We obtained helical CT scans with a tube current of 150 mA, voltage of 120 kV and 2:1 pitch (table speed in relation to slice thickness), starting at the upper edge of the liver and continuing to the pelvis. The intra-abdominal visceral fat volume was measured by drawing a line within the muscle wall surrounding the abdominal cavity. The abdominal subcutaneous fat volume was calculated by subtracting the visceral fat volume from the total abdominal fat volume. The intra-abdominal visceral and subcutaneous fat areas were determined at the umbilical level by the previously reported CT scanning technique.7,8
Measurement of serum leptin
Measurement of serum leptin was carried out by a radioimmunoassay as described by Zhongmin et al.22 This assay measures the total (free plus bound) leptin in the blood. Sensitivity was 0.5 ng/ml and the intra-assay and interassay coefficients of variation were less than 3 and 8%, respectively.
Statistical analysis
StatView-J 5.0 software was used for all statistical analysis in this study. Values are shown as mean±s.d. Simple linear correlations, Pearson's correlation coefficients and partial correlation analysis were carried out. A difference with a P-value <0.05 was considered to be statistically significant.
|
 Results
Intra-adbdominal visceral fat volume (Vvol), measured by helical CT, was found to be positively correlated with visceral fat area (Varea) measured by conventional slice-by-slice CT in both genders (Figure 1). Intra-abdominal subcutaneous fat volume (Svol) also showed a positive correlation with subcutaneous fat area (Sarea) in both genders (Figure 2). We then investigated the respective correlations of BMI vs Vvol, Varea, Svol or Sarea in both genders. Subcutaneous fat mass correlated with BMI more strongly than visceral fat mass both in terms of area and volume. Vvol was found to have a stronger correlation with BMI than Varea in both genders (Table 2).
We then analyzed the correlation between intra-abdominal fat mass vs serum lipids (Table 3). Varea and Vvol showed a positive correlation with serum TG levels in men, whereas in women this association was not observed. In both genders, subcutaneous fat showed a weak inverse correlation with serum HDL-C level. However, serum TC did not show correlation with any of intra-abdominal fat mass.
To determine how intra-abdominal fat mass affects serum leptin levels, we analyzed the correlations of BMI, subcutaneous or visceral fat mass vs serum leptin levels in a subset of these subjects (men (n=26), age 48±15 y, BMI 30±5.0 kg/m2, leptin 6.5±3.4 ng/ml; women (n=26), age 56±12 y, BMI 29±3.8 kg/m2, leptin 15±7.8 ng/ml). In both genders, BMI correlated positively with serum leptin levels (men, r=0.69, P=0.0004; women, r=0.67, P=0.0002). We then investigated the relationship between subcutaneous fat mass and serum leptin levels. Subcutaneous fat mass, either volume or area, correlated with serum leptin more strongly than BMI in both genders. In both genders, the correlation coefficient was higher in Svol vs leptin than Sarea vs leptin (men, r=0.73, P<0.0001 for Sarea vs leptin; r=0.74, P<0.0001 for Svol vs leptin; women, r=0.73, P<0.0001 for Sarea vs leptin; r=0.75, P<0.0001 for Svol vs leptin). Next we investigated the relationship between visceral fat mass and serum leptin levels. In men neither Vvol nor Varea showed significant correlation with serum leptin levels (r=0.33, P=0.10 for Vvol vs leptin; r=0.20, P=0.31 for Varea vs leptin), whereas in women, both Vvol and, to a lesser degree, Varea had a positive correlation with serum leptin (r=0.58, P=0.002 for Vvol vs leptin; r=0.41, P=0.035 for Varea vs leptin). The correlation between Varea vs serum leptin in women did not persist after adjustments for Vvol, while Vvol was still positively correlated with serum leptin after adjustments for Varea (data not shown).
|
 Discussion
In the present study we have described a novel method of assessing intra-abdominal fat mass using helical CT, which made it possible to measure fat volume. The main findings of the present study were as follows: (1) there were strong positive associations between intra-abdominal Vvol and Svol measured by helical CT vs respective fat areas assessed by conventional slice-by-slice CT in both genders; (2) Vvol showed a stronger correlation with BMI than Varea in both genders; (3) in men, Varea and Vvol showed a positive correlation with plasma TG levels; (4) in both genders, intra-abdominal visceral fat mass showed a weaker correlation with serum leptin levels than did subcutaneous fat mass.
Helical CT is a rather new, advanced technique used for diagnosing several disorders.1,3,4 However, until recently, there had been no report describing its application to the assessment of intra-abdominal body fat distribution. In 1998, it was clarified by using low-dose helical CT technique in 24 post-gastrectomy subjects comprising nine women and 15 men with a mean age of 60 y, that percentage fat and percentage subcutaneous fat were significantly greater in women than was percentage intra-abdominal fat in men.5 However, they did not study the correlation between fat volumes by helical CT vs those respective areas measured using conventional methods.
One of the great advantages of measuring intra-abdominal body fat volumes over measuring those respective areas is assumed to be that measuring fat volumes reflects body fat mass more precisely than measuring the respective areas. Indeed, in our study, visceral fat volume showed a stronger correlation with BMI than visceral fat area in both genders (Table 2).
Another method of measuring intra-abdominal fat volume distribution has been by magnetic resonance imaging (MRI). Total body MRI studies have demonstrated that intra-abdominal visceral fat volume is relatively small, 0.5-8.5 1 in men and 0.9-5.5 1 in obese women, and accounts for only 6-20% of total adipose tissue volume in obese individuals.23,24 The results of the present study, showing that visceral and subcutaneous fat accounts for 47 and 53%, respectively, of intra-abdominal total fat volume in men, whereas in women they account for 32 and 68%, respectively (Table 1), also indicated that visceral fat volume accounted for less than subcutaneous fat volume.
Considering the fact that the method of evaluating intra-abdominal visceral fat area using conventional CT clarified that this fat plays an important role in the development of hyperlipidemia,7,8,9,10 we also analyzed in this study the relationship between fat mass measured by helical CT vs serum lipids. The result that in men visceral fat mass showed a positive correlation with plasma TG levels is consistent with the previous findings.8,9 This was not the case in women, which may be relevant to the fact that the present study included both pre- and post-menopausal women.
There are conflicting reports as to whether plasma leptin is associated with total body, subcutaneous or visceral adipose tissue.25,26,27 Our present findings indicate that in both genders subcutaneous fat mass shows a stronger association with serum leptin than BMI or visceral fat mass.
In conclusion, we have reported a new technique for measuring intra-abdominal fat volume by the use of helical CT, which potentially reflects intra-abdominal fat mass more precisely than conventional slice-by-slice CT at the umbilical level.
|
 |
| References |
 |
1 Kalender WA, Polacin A. Physical performance characteristics of spiral CT scanning. Med Phys 1991; 18: 910-915. MEDLINE
2 Rigaus H, Marchal G, Baert AL, Hupke R. Spiral scanning and the influence of the reconstruction algorithm on image quality. J Comput Assist Tomogr 1990; 14: 675-682. MEDLINE
3 Heiken JP, Brink JA, Vannier MW. Spiral (helical) CT. Radiology 1993; 189: 647-656. MEDLINE
4 Zeman RK, Fox SH, Silverman PM, Davros WJ, Carter LM, Griego D, Weltman DI, Ascher SM, Cooper CJ. Helical (spiral) CT of the abdomen. Am J Roentgenol 1993; 160: 719-725.
5 Rogalla P, Meiri N, Hoksch B, Boeing H, Hamm B. Low-dose spiral computed tomography for measuring abdominal fat volume and distribution in a clinical setting. Eur J Clin Nutr 1998; 52: 597-602. MEDLINE
6 Vague J. The degree of masculine differentiation of obesities, a factor determining predisposition to diabetes, atherosclerosis, gout and uric calculous disease. Am J Clin Nutr 1956; 4: 20-34.
7 Tokunaga K, Matsuzawa Y, Ishikawa K, Tarui S. A novel technique for the determination of body fat by computed tomography. Int J Obes 1983; 7: 437-445. MEDLINE
8 Taira K, Hikita M, Kobayashi J, Bujo H, Takahashi K, Murano S, Morisaki N, Saito Y. Delayed post-prandial lipid metabolism in subjects with intra-abdominal visceral fat accumulation. Eur J Clin Invest 1999; 29: 301-308. Article MEDLINE
9 Couillard C, Bergeron N, Prud'homme D, Bergeron J, Tremblay A, Bouchard C, Mauriege P, Després JP. Postprandial triglyceride response in visceral obesity in men. Diabetes 1998; 47: 953-960. MEDLINE
10 Larsson B, Svardsudd K, Welin L, Wilhelmsen L, Björntorp P, Tibblin G. Abdominal adopose tissue distribution, obesity and risk of cardiovascular disease and death: 13 y follow up of participants in the study of men born in 1913. Br Med J Clin Res 1984; 288: 1401-1404.
11 Spiegelman BM, Flier JS. Adipogenesis and obesity: rounding out the big picture. Cell 1996; 87: 377-389. MEDLINE
12 Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature Med 1994; 372: 425-432.
13 Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 1998; 395: 763-770. Article MEDLINE
14 Monitat M, Deng C, Muzzin P. Assimacopoulos-Jeannet F, Seydoux J, Dulloo AG, Giacobino JP. Modulation of obese gene expression in rat brown and white adipose tissues. FEBS Lett 1995; 373: 131-134. MEDLINE
15 Leroy P, Dessolin S, Villageois P, Moon BC, Frieman JM, Ailhaud G, Dani C. Expression of ob gene in adipose cells. Regulation by insulin. J Biol Chem 1996; 271: 2365-2368. MEDLINE
16 Hwa JJ, Fawzi AB, Graziano MP, Ghibaudi L, WIlliams P, Van Heek M, Davis H, Rudinski M, Sybertz E, Strader CD. Leptin increases energy expenditure and selectively promotes fat metabolism in ob/ob mice. Am J Physiol 1997; 272: R1204-1209. MEDLINE
17 Ryan AS, Elahi D. The effects of acute hyperglycemia and hyperinsulinemia on plasma leptin levels: its relationships with body fat, visceral adiposity, and age in women. J Clin Endocrinol Metab 1996; 81: 4433-4438. MEDLINE
18 Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Rangathan S, Kern PA, Friedman JM. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Med 1995; 1: 1155-1161. MEDLINE
19 Dua A, Hennes MI, Hoffmann RG, Maas DL, Krakower GR, Sonnenberg GE, Kissebah AH. Leptin: a significant indicator of total body fat but not of visceral fat and insulin insensitivity in African-American women. Diabetes 1996; 45: 1635-1637. MEDLINE
20 Banerji MA, Faridi N, Atluri R, Chaiken RL, Lebovitz HE. Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men. J Clin Endocrinol Metab 1999; 84: 137-144. MEDLINE
21 Ronnemaa T, Kronen SL, Rissanen A, Koskenvno M, Koivisto VA. Relation between plasma leptin levels and measures of body fat in identical twins discordant for obesity. Ann Intern Med 1997; 126: 26-31. MEDLINE
22 Zhongmin M, Gingerich RL, Santiago JV, Klein S, Smith CH, Landt M. Radioimmunoassay of leptin in human plasma. Clin Chem 1996; 42: 942-946. MEDLINE
23 Ross R, Leger L, Morris D, de Guise J, Guardo R. Quantification of adiopose tissue by MRI: relationship with anthropometric variables. J Appl Physiol 1992; 72: 787-795. MEDLINE
24 Ross R, Shaw KD, Martel Y, deGuise J, Avruch L. Adipose tissue distribution measured by magnetic resonance imaging in obese women. Am J Clin Nutr 1993; 57: 470-475. MEDLINE
25 Lonnqvist F, Arner P, Nordfors L, Schalling M. Overexpression of the obese (ob) gene in adipose tissue of human obese subjects. Nature Med 1995; 1: 953-956. MEDLINE
26 Considine RV, Sinha M, Heiman ML, Kriauciunos A, Stephens TW, Nyce MR, Phannesian JP, Marco CC, Mcker LJ, Bauer TL, Caro JF. Serum immunoreactive leptin concentrations in normal weight and obese humans. New Engl J Med 1996; 334: 292-295. MEDLINE
27 Ramchandaran A, Snehalatha C, Vijay K, Styavani E, Latha S, Haffner SM. Plasma leptin in non-diabetic Asian Indians: association with abdominal adiposity. Diabetic Med 1997; 14: 937-941. MEDLINE
|
 |
| Figures |
 |
Figure 1 Correlation between visceral fat area measured by conventional CT, and visceral fat volume measured by helical CT in men (A) and women (B). |
Figure 2 Correlation between subcutaneous fat area measured by conventional CT, and subcutaneous fat volume measured by helical CT in men (A) and women (B). |
 |
| Tables |
 |
Table 1 Clinical profile of the study subjects |
Table 2 Correlations of several adipose tissue distribution variables to body mass index |
Table 3 Correlation between abdominal fat mass vs serum lipids |
 |
 |
 |
| Received 25 January 2001; revised 25 July 2001; accepted 16 October 2001 |
 |
| March 2002, Volume 26, Number 3, Pages 398-402 |
 |
| Table of contents Previous Article Next [PDF] |
|
|